ImmuneWatch at Swiss Biotech Day 2026

We are excited to announce that ImmuneWatch will be represented at Swiss Biotech Day 2026, one of Europe's premier biotechnology conferences, taking place on May 4–5, 2026 at the Congress Center Basel, Switzerland.

CEO Sander Wuyts and COO Tom Bosschaerts will both be attending, and are eager to connect!

Meet us in Basel

ImmuneWatch is on a mission to become the standard TCR specificity platform. Our flagship ImmuneWatch DETECT enables researchers and clinical teams to annotate T-cell receptor (TCR) sequences with epitope specificity at scale. It's a critical capability to increase understanding of TCR repertoires for TIL therapy development, immune monitoring in clinical trials, and reactive T-cell research.

If you are working in:

• Cell therapy (TIL, TCR-T)
• Oncology or infectious disease immunology
• Biopharma clinical development
• Biotech investment or partnering

…we would love to meet.

Also, we're bringing a live demo of our newest product: integration of ImmuneWatch DETECT in your favourite LLM. Nowadays you can just ask Claude or ChatGPT to annotate the specificity of your TCRs.

Schedule a meeting

Reach out to us to schedule a one-to-one meeting during the event. We look forward to connecting with you in Basel!